Background: GPR120, a G protein-coupled receptor for long-chain polyunsaturated fatty acids (FAs), mediates the antiinflammatory effects of omega-3 (x-3) FAs. We investigated whether host or tumor GPR120 plays a role in the anti-prostate cancer effects of x-3 FAs. Methods: MycCap prostate cancer allografts were grown in immunocompetent wild-type (WT) and GPR120 knockout (KO) mice fed x-3 (fish oil) or x-6 (corn oil) diets. Immune cell infiltration was quantified by flow cytometry, and gene expression of immune cell markers in isolated tumor-associated macrophages (TAMs) was quantified by quantitative real-time polymerase chain reaction. Archived tissue from a fish oil intervention trial was used to correlate gene expression of GPR120 with cell cycle progression (CCP) genes and Ki67 index (n ¼ 11-15 per group). All statistical tests were two-sided. 
In preclinical studies, it is well established that dietary x-3 fatty acids (FAs) from fish oil decrease tumor growth in various mouse models of prostate cancer in immune-deficient and immunocompromised mouse strains (1) (2) (3) (4) (5) . Epidemiologic studies, however, are inconclusive with regards to the association between fish oil intake and risk of overall and advanced prostate cancer (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Due to a lack of prospective randomized studies, little is known about the clinical benefit of fish consumption or fish oil supplementation for prostate cancer prevention and/or treatment. Recently we reported that a fish oil diet delayed prostate cancer allograft tumor growth in immune-competent FVB mice and decreased tumor-associated macrophage (TAM) infiltration in tumor tissue (5) . Macrophages are highly plastic cells and respond to the surrounding stimuli to develop tissuespecific functions (16) . Distinct states of polarized TAMs have been identified: the "classically" activated (M1) macrophages have tumoricidal activity whereas the "alternatively" activated (M2) macrophages promote tissue repair and angiogenesis and favor tumor progression via immune suppression (17) . The majority of TAMs in prostate cancer are the M2 subtype (16) . M2 polarized TAMS are associated with high tumor grade and poor prognosis in patients with prostate cancer (16) (17) (18) . As TAMs represent a functionally diverse group of macrophages with a spectrum of activation states, the terminology "M1-like" and "M2-like" is often used for in vivo studies in recognition of the variation in functional states (19) .
The mechanism through which omega-3 fatty acids exert their anticancer effects remains under investigation (20) . GPR120 is a G protein-coupled receptor involved in modulation of metabolism and endocrine and immune function. GPR120 can be activated by polyunsaturated long-chain fatty acids (21) . Oh et al. reported that GPR120 was highly expressed in adipose tissue and pro-inflammatory macrophages in mice fed a highsaturated fat diet and that addition of fish oil containing DHA and EPA exerted potent anti-inflammatory effects through GPR120 (22) . In addition, genome-wide association (GWAS) studies have shown that dysfunction of GPR120 due to a single nucleotide polymorphism (SNP) of GPR120 is associated with obesity (23) . In human prostate cancer cells, Liu et al. reported that GPR120 was activated by x-3 FAs and other GPR120 agonists to inhibit cell proliferation in vitro (24) .
Given the prior discovery that GPR120 is a receptor for x-3 fatty acids, we sought to determine if GPR120 plays a role in the anti-prostate cancer effect of dietary x-3 FAs. Likewise, given that dietary x-3 FAs were previously shown to inhibit M2-like TAM function in prostate cancer allografts, we also investigated if the x-3 FAs are acting on TAMs via the GPR120 receptor. Using archived tissue from a prior preprostatectomy trial, in which a low-fat diet plus fish oil supplements exerted antiproliferative effects on prostate cancer epithelium, we also examined if expression of GPR120 in the stroma correlates with the antiproliferative effects.
Methods

Animal Husbandry, Feeding Protocol, and MycCaP Allograft Tumors
Male FVB mice (eight weeks old) were obtained from Jackson Laboratory (Bar Harbor, ME). The mice were housed individually to monitor and measure food intake. The experiments were approved by the UCLA Animal Research Committee, and the mice were cared for in accordance with institutional guidelines. Mice were acclimated for seven days on a standard AIN-93G diet (DYETS, Bethlehem, PA); 5Â10 5 MycCaP cells (prostate cancer cell line from Hi-Myc transgenic mice) were injected subcutaneously into the flank of wild-type (WT) and GPR120 knockout (KO) mice. When tumor volumes reached 30-50 mm 3 ; mice were randomly assigned to either an x-3 or x-6 diet. The diets were prepared by DYETS, Inc. (Bethlehem, PA), as previously described (15) . Both diets provided 30% of energy (kcal) from fat, with the fat source being either fish oil (x-3 diet) or corn oil (x-6 diet). Mice were sacrificed six weeks after the MycCaP cells were injected. Tumor tissue was weighed and rinsed with cold phosphate buffered saline (PBS); 100 mg of the tumor tissue was snap-frozen in liquid nitrogen, and the remaining tissue was used for flow cytometry and immune cell isolation (Supplementary Materials, available online). Materials  and  Supplementary Tables 1 and 2 , available online) (5).
Cell Viability Assay
Cell viability was determined using the CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (Promega). Further details can be found in the Supplementary Materials (available online).
ShRNA Knockdown of GPR120 in THP-1 M2 Macrophages GPR120 shRNA (GE dharmacon) was transfected into THP-1 cells with Lipofectamine 2000 (Invitrogen). Forty-eight hours after transfection, cells were selected with puromycin. The expression was confirmed by RT-PCR (Supplementary Materials, available online).
Collection of Stromal Tissue From Human Prostate Tumors
Archived prostate tissue was obtained from a previously completed phase II randomized preprostatectomy trial (NCT00836615), in which participants were randomly assigned to either a low-fat fish oil intervention (dietary x-6 to x-3 ratio of 2:1) or control (dietary x-6 to x-3 ratio of 15:1) group (25) . Details of the clinical trial have been previously described (25) . Stromal tissue (n ¼ 11-15 per group) was collected from malignant radical prostatectomy tissue by laser capture microdissection using the Leica LMD7000 (Leica Microsystems Inc, Buffalo Grove, IL). RNA was extracted, and quantitative RT-PCR was performed as described above.
Statistical Analysis
The difference in tumor growth rates (slope after diet change) of allograft tumors between the two dietary groups (x-3 and x-6 diet) was evaluated for WT and KO mice separately using generalized estimating equations (GEE) models, including terms for mouse, group, time, and a group*time interaction term (SAS V9.4, Cary, NC). Quantitative measures (final tumor volume and weight, M1, M2-like macrophages, mRNA levels, etc.) were compared using the Student t test in GraphPadPrism 6.0 software (GraphPad Software, La Jolla, CA). The association between tissue Ki-67 immunostaining and GPR120 gene expression or cell cycle progression (CCP) score was evaluated using Spearman's correlation coefficient. The data are presented as mean 6 standard deviation, unless otherwise noted. In vitro experiments were performed in triplicate. P values of less than .05 were considered statistically significant. All statistical tests were twosided.
Results
Effect of GPR120 Global Knockout on Dietary Omega-3 Fatty Acid Inhibition of Prostate Tumor Growth
To study if GPR120 is required for omega-3 fatty acids to delay prostate tumor growth, we knocked out GPR120 in FVB mice using the CRISP-Cas9 system (GPR120 -/-). Heterozygous mutation in F0 mice was verified by genomic sequencing (Supplementary Figure 1A , available online). Protein levels of GPR120 in the spleen and adipose tissue from GPR120 -/-mice were decreased compared with WT mice (Supplementary Figure 1B, 
Effect of GPR120 in MycCaP Cells on Omega-3 Fatty Acid Inhibition of Prostate Tumor Growth
To examine if functional GPR120 is required in MycCaP cells for the anticancer effects of dietary x-3 fatty acids, we knocked out GPR120 in the MycCaP cell line using the CRISPCas9 system (GPR120 -/-). Immunoblot showed that GPR120 3 , WT or GPR120 -/-mice were randomly assigned to either the x-3 or x-6 diet (n ¼ 8 for WT x-6 diet; n ¼ 7 for WT x-3 diet; n ¼ 7 for GPR120 -/-x-6 diet; n ¼ 7 for GPR120 -/-x-3 diet). A) Tumor volume was determined three times per week. B) Tumor weight at the time of death. C) Eight-week-old male immunocompetent WT mice were fed an AIN93G diet for one week before injection of 5 Â 10 5 GPR120 knockout MycCaP cells in the flank. When tumors became palpable, mice were randomly assigned to either the x-3 or x-6 diet (n ¼ 7 for x-6 diet; n ¼ 8 for x-3 diet), and tumor volumes were measured three times per week. Data are presented as mean 6SD; two-sided Student t test was used to compare final tumor volume between diet groups for WT and knockout mice separately. WT ¼ wild-type.
ARTICLE Effect of GPR120 Knockout on Dietary Omega-3 Fatty Acid Inhibition of M2 Macrophage Function
Immune cell infiltration in the allograft tumors was determined by flow cytometry. In the allograft tumor tissue, 80% of CD45þ cells were macrophages (F4/80); 50%-70% of CD45þ/F4/80þ macrophages were CD206þ (M2-type), and 2%-10% were CD68þ (M1-type) (Figure 2A ). WT mice fed the x-3 diet had fewer F4/80þCD206þ M2 polarized macrophages than WT mice fed the x-6 diet (53. -/-mice (data not shown). We isolated CD206þ (M2) macrophages from tumor tissue using magnetic beads to study the effect of the x-3 diet on M2-like macrophage markers, cytokines, chemokines, and growth factors. Gene expression of CD206, Arg1, TNF-a, CCL2, CCL22, MMP-9, and VEGF was decreased in isolated CD206þ cells from allograft tissue of the x-3 group compared with the x-6 group from WT mice, but not from GPR120 -/-mice ( Figure 2B ). GPR120-/-x-6 diet; n ¼ 7 for GPR120-/-x-3 diet). B) CD206þ M2 macrophages from tumor tissue from WT and GPR120 KO mice were isolated using magnetic beads, and gene expression was analyzed by quantitative real-time polymerase chain reaction on sorted cell populations (n ¼ 5 for WT x-6 diet; n ¼ 5 for WT x-3 diet; n ¼ 5 for GPR120-/-x-6 diet; n ¼ 5 for GPR120-/-x-3 diet). Data are presented as mean 6 SD; two-sided Student t test was used to compare macrophage number and gene expression between diet groups for WT and KO mice separately. Arg1 ¼ arginase 1; CD206 ¼ cluster of differentiation 206 or mannose receptor; DHA ¼ docosahexaenoic acid; CCL2 ¼ C-C motif chemokine ligand 2; CCL22 ¼ C-C motif chemokine ligand 22; IL-4 ¼ interleukin 4; IL-10 ¼ interleukin 10; MMP-9 ¼ matrix metalloproteinase-9; TNF-a ¼ tumor necrosis factor alpha; VEGF ¼ vascular endothelial growth factor; WT ¼ wild-type.
Effect of GPR120
Effect of DHA on Expression of M2 Macrophage Markers and Cytokines in Vitro
The in vitro effects of DHA on M2 polarized macrophage markers and cytokines mirrored the in vivo findings. Murine RAW264.7 macrophage cells were induced to M2-like macrophages using IL-4. DHA pretreatment of RAW264.7 M2 polarized macrophages decreased expression of CD206, Arg1, CCL22, TNF-a, VEGF, and MMP-9 ( Figure 4, A-F) .
Effect of DHA on Migration of Prostate Cancer Cells Cocultured With GPR120-Specific Knockdown M2 Macrophages and Scramble Controls
Coculture of 22RV1 prostate cancer cells with THP-1 M2 polarized macrophages increased migration of tumor cells through the Matrigel layer ( Figure 5C ). Treatment of THP-1 polarized M2 macrophages with DHA decreased migrating 22RV1 cells/field (from 64 [6] to 42 [6] ; P ¼ .01). Knockdown of GPR120 in the THP-1 polarized M2 macrophages reversed the inhibitory effect of DHA on 22RV1 migration ( Figure 5C ).
Correlation of GPR120 Expression in Prostate Cancer Stromal Tissue With the Antiproliferative Effects of Fish Oil in Human Archived Specimens
In a prior preprostatectomy study, we reported that a low-fat fish oil (LFFO) supplemented diet that lowered the dietary ratio of x-6 to x-3 FAs resulted in lower gene expression of a cell cycle progression signature (CCP score) and lower proliferation (Ki-67 index) in malignant epithelium as compared with subjects receiving a control Western diet (25) . For the present study, we laser-captured stroma adjacent to malignant epithelium from the radical prostatectomy specimens from 12 patients in the LFFO group and 15 patients from the Western diet group and measured the gene expression of GPR120. CPP score data were available from 12 patients in the LFFO group and 11 patients in the Western diet group. In the LFFO group (but not the Western diet group), higher GPR120 gene expression correlated with lower CCP score (r ¼ -.57, P ¼ .04) but did not reach statistical significance with the Ki-67 index (r ¼ -.54, P ¼ .07) ( Figure 6 ).
Discussion
In the present study, using an immunocompetent prostate cancer allograft model, we found that a x-3 FA diet (as compared with a x-6 FA diet) decreased prostate tumor growth and decreased the number and function of bone marrow-and tissuederived M2-like macrophages. These effects were reversed in GPR120 knockout mice. However, the x-3 FA diet inhibited growth of GPR120 knockout MycCaP allografts in wild-type mice. These studies point to host GPR120 as playing a central role in the anticancer effects of dietary x-3 FAs. Macrophages are highly plastic cells that respond to the surrounding stimuli to develop tissue-specific functions (16) . In the case of prostate cancer, evidence suggests that M2-like TAMS in the tumor microenvironment play a key role in prostate cancer progression and metastasis (16, 26, 27) . Prior reports suggest that M2-like TAMS promote tumor progression through a number of mechanisms including immunosuppression and promotion of invasion/migration and angiogenesis through release of cytokines (IL-10, CCL2, TGFb), chemokines (CCL22, CCL17), and growth factors (VEGF) (27, 28) . In the present study, we isolated M2-like TAMS (CD206þ) from allograft tumors from mice fed x-3 or x-6 diets and found that M2-like TAM numbers and gene expression of M2-related cytokines, chemokines, and growth factors were statistically significantly reduced in the x-3 diet group (compared with the x-6 group). However, this antimacrophage effect of the x-3 diet was not seen in isolated M2-like TAMs from the GPR120 KO mice. Furthermore, bone marrow isolated from the wild-type and GPR120KO mice and induced to become M2-TAMs showed similar results when exposed to DHA (x-3 FA) in vitro. In the present study, we also cocultured human M2 macrophages derived from THP1 monocytes with a human prostate cancer cell line (22RV1) and found that the inhibitory effect of DHA-treated M2 macrophages on 22RV1 migration/invasion was reversed by knocking out GPR120 in the THP1 monocytes. These data all support our hypothesis that x-3 FAs exert anticancer effects through GPR120 on host M2-like TAMs. Establishing a causal relationship, however, will require future studies incorporating animal models that knock out GPR120-dependent macrophage function. Further studies are also warranted on the effects of omega-3 fatty acids on other subpopulations of macrophages that may play a role in prostate cancer pathogenesis (29) .
In the present study, we also examined the role of host GPR120 by examining archived tissue from a prospective trial we previously conducted in which men undergoing radical prostatectomy were randomly assigned to a low-fat diet with fish oil supplementation or a Western diet (25) . We previously reported that there was lower gene expression of a commercially available gene signature for cell cycle progression (CCP score) and lower proliferation (Ki-67 index) in the malignant epithelium in the prostatectomy specimens in the LFFO group as compared with the Western diet group in men with prostate cancer (30) . CCP score and Ki-67 index correlate with prostate cancer progression and prostate cancer-specific death (30, 31) . We found that in the LFFO group (but not the Western diet group), higher GPR120 gene expression in the stroma correlated with lower CCP score and there was a trend for higher GPR120 gene expression to correlate with lower Ki-67 index in the malignant epithelium. The findings of a correlation between GPR120 and CCP/Ki67 suggest that patients with higher GPR120 expression may potentially be better responders to fish oilbased interventions, thus allowing a precision approach to fish oil therapy.
Limitations of these studies on laser-captured tissue are the small sample size (11-15 patients per group) and that these were post hoc analyses. We are testing the hypothesis that patients with higher GPR120 status in prostate cancer tissue may predict greater responsiveness to fish oil in an ongoing prospective randomized trial we are conducting in men with prostate cancer on active surveillance (NCT02176902).
Further studies are required to elucidate the mechanisms whereby fish oil exerts anticancer effects directly on prostate cancer cells and through host-related mechanisms (32) . With regards to potential host mechanisms, with suppression of tumor-associated M2-like TAMs, one would expect reversal of the M2-induced immunosuppressive effects and an increase in cytotoxic T cells (28) . We did not find this to be the case on flow cytometry studies of tumor allografts. This may be due to low baseline levels of cytotoxic T cells in our animal model. M2-like TAMs promote cancer progression through other mechanisms besides immunosuppression, such as angiogenesis, matrixdegrading enzymes, and epithelial mesenchymal transition (27) . In the current study, dietary fish oil decreased gene expression of the proangiogenic factor VEGF and the proteolytic enzyme MMP9 in M2 macrophages. Future studies are needed to determine if fish oil inhibits prostate cancer progression through these other M2-like TAM-related mechanisms (33) . In summary, we found that host GPR120 plays a central role in the anticancer effects of dietary x-3 FAs, possibly by reducing the number and function of M2-like TAMS. Given the known link between M2-like macrophages and prostate cancer progression, clinical trials that evaluate the efficacy of fish oil in prostate cancer patients are warranted. Given the correlation between GPR120 expression and the antiproliferative effects of a low-fat fish oil intervention, further studies are warranted that evaluate if host GPR120 expression predicts efficacy of fish oil therapy, thus allowing a precision approach to fish oil interventions.
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